Study of TRAVATAN in Subjects With Iris Pigmentation Changes

You may be eligible if

• Inclusion:
• Diagnosis of open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component) or ocular hypertension;
• Has experienced an iris pigmentation change while dosing with TRAVATAN;
• Currently dosing with TRAVATAN;
• Exclusion:
• Any form of glaucoma other than open-angle glaucoma (with or without a pigment dispersion or pseudoexfoliation component) or ocular hypertension;
• Not currently using TRAVATAN;
• Females of childbearing potential if pregnant, breast-feeding, or not using highly effective birth control measures;
• History of any severe ocular pathology (including severe dry eye);